GM says it is going to double income by 2030 in digital push to be seen extra like Tesla

DETROIT – General Motors plans to double its annual sales to $ 280 billion by the end of this decade as the company migrates to all-electric vehicles and diversifies beyond auto and truck sales.

The automaker announced on Wednesday ahead of investor presentations detailing how the company will operate plans to achieve these goals through traditional automotive businesses and new software and data-driven businesses.

The revenue target is based on a moving average of about $ 140 billion for the automaker over the past few years, a company spokesman said. GMs Sales last year was nearly $ 122.5 billion, down 10.8% from 2019, largely due to factory closures at the start of the coronavirus pandemic. The operating profit margin in 2020 was 7.9%.

“If you look at all of the investments we’ve made in over five years, we’re really in execution mode today,” GM CEO and Chairman Mary Barra told reporters during a pre-event briefing. “We have great confidence in our ability to increase sales.”

The two-day investor meeting including product test drives on Thursday is intended to provide a “clear strategy” to convince investors to like the company more like a technology start-up Tesla, which is valued at more than $ 750 billion compared to $ 79 billion for GM.

Barra said GM expects much of the sales growth to come from its new and service-based businesses, with “moderate growth” from its traditional vehicles and operations.

“We are seeing a surge in EVs especially in the first few days, so we see tremendous opportunities to grow from an EV perspective and then subscriptions and services,” she said.

The automaker expects its traditional auto sales and financing business to grow from $ 138 billion to $ 195 billion to $ 235 billion a year. Its new businesses such as the autonomous vehicle subsidiary Cruise and BrightDrop commercial EV business is expected to grow from $ 2 billion, mostly from OnStar, to $ 80 billion over this period.

GM also confirmed plans to rapidly scale its electric vehicle manufacturing, with more than 50% of its plants in North America and China able to produce the vehicles. Currently, only two GM plants in North America are capable of producing electric vehicles, but the company has announced plans to convert at least three more by 2023.

GM President Mark Reuss told investors on Wednesday that the company would soon announce a second battery-electric truck assembly plant. The company’s first EV pickups, including the upcoming ones GMC lobster, is produced in a facility in Detroit.

The automaker is about to Invest 35 billion dollars in electric and autonomous vehicles by 2025, as the company aims to become a fully electric automaker by 2035.

GM said it plans to outperform Tesla as the U.S. leader in electric vehicles, but Barra and Reuss declined to give a timeframe. The company has announced that it will sell 1 million electric vehicles per year worldwide through 2025.

During the event, GM is also expected to explain in more detail this transition as well as the planned commercialization of driver assistance systems and autonomous vehicles.

GM confirmed on Wednesday that it will introduce its new one electric Silverado at CES in January. It is also said that a Chevrolet crossover is in the works for around $ 30,000. GM did not announce any sales dates for the vehicles.

“Nobody will be able to touch us in the battery-electric truck room,” Reuss told reporters on Wednesday. “You will see that we hit the mark with that.”

Regarding self-driving technology, GM said it will launch a new hands-free system in 2023 called “ultra-cruise” that is roadworthy in 95% of the scenarios. The system is expected to be far more powerful than its current Super Cruise system, which is only available on pre-mapped shared highways.

At launch, according to GM, Ultra Cruise will be available on more than 2 million kilometers of road in the US and Canada. Great cruise is currently available on more than 200,000 kilometers of road.

2022 GMC Hummer EV Sport Utility Truck


Ambush-style assaults concentrating on police greater than double over the previous yr

FORT MYERS, Florida – The National Fraternal Order of Police (FOP) reports that ambush attacks on officers have increased 103% year over year (2020).

The latest report from the FOP says there have been 75 ambush attacks on officials in the past year.

Of these attacks, 93 officers were shot dead and 21 killed.

The FOP says that an ambush style attack is defined as any time an officer is shot without warning or defense.

Fox 4 spoke to Lt. Jason Pate of the Fort Myers Police Department (FMPD), whose job it is to train officers in all situations, including ambush attacks.

“Every call we make has the potential to be ambushed,” said Godfather.

Godfather says preparing for the unpredictable requires unique training.

“We always try to introduce a scenario in which there is something that surprises the officer, that something unusual happens to the officer. It could be to sit down, eat while you (officer) are on duty, during weapons training and then a threat comes up and you have to react, ”said Godfather.

Godfather says that not every workout involves a reaction in self-defense.

He says sometimes it’s about showing officers how to relate to the people they serve.

“They see us as a uniform, the blue as a badge, they don’t see us as people. And if they see us as human a little more often and we can build a personal connection, someone could change their mind, recognize us and say, I knew this officer and he treated me fairly, “said Godfather.

It’s a lesson he gives every officer and one he says will only take a few minutes.

four Market-Topping Dividend Shares That Can Double Your Cash by 2026

There are a number of ways for investors to make money on Wall Street. However, Dividend stocks stand head and shoulders above their colleague.

In 2013, JP Morgan Asset Management published a report comparing the performance of companies that paid and increased their dividends over a four-decade period (1972-2012) with non-dividend stocks. The result? Dividend paying stocks delivered and average annual profit of 9.5% over 40 years. In comparison, the non-dividend-bearing companies achieved an annualized return of a meager 1.6% over the same period.

Since dividend stocks are often profitable and proven, they are the ideal way for long-term investors to use their money in any economic environment.

If you’re looking for market-leading dividend stocks – that is, companies that generate a return that of the broader ones. is superior S&P 500 – Which can generate significant wealth and income, the following four have the potential to double your money by 2026.

Image source: Getty Images.

AGNC Investment Corp .: 8.8% return

For most of the last decade, mortgage real estate investment trusts (REITs) have been Wall Street’s underdogs. But with certain economic factors now working in their favor, the next five years will be could be particularly cheap for an extremely high-yielding stock like AGNC Investment Corp. (NASDAQ: AGNC).

For mortgage REITs, pretty much nothing is more important than interest rates. This is because mortgage REITs borrow money at short-term borrowing rates in order to use that capital to purchase mortgage-backed securities (MBSs) that offer higher long-term returns. AGNC and its competitors are constantly looking for ways to maximize the difference between the average return on assets it holds and the average cost of borrowing. This difference is known as the net interest margin.

The great thing for investors is that the mortgage REIT space is transparent. When the yield curve flattens out (that is, the gap between short-term and long-term returns narrows) or when the Federal Reserve changes monetary policy quickly, mortgage REITs like AGNC do poorly. Conversely, companies like AGNC thrive when the yield curve steepens and the Fed announces its moves in an orderly fashion. We are 100% in the latter scenario right now and will likely stay in that scenario for years to come.

When the US economy takes hold, we should witness one slow but steady expansion the net interest margin of AGNC. Coupled with the use of leverage to increase profitability, AGNC Investment has a good chance of generating serious income for shareholders and a modest average annual return on its shares through 2026.

A flowering cannabis plant in a commercial indoor grow farm.

Image source: Getty Images.

Innovative industrial real estate: 2.3% return

Try this for size: A Marijuana stock it pays off.

While it is unusual for a high-growth company to pay a dividend, it is perfectly normal for a REIT to distribute most of its profits to its shareholders in the form of a dividend. This is exactly the case with the cannabis-focused REIT Innovative industrial real estate (NYSE: IIPR).

Innovative Industrial Properties, or IIP for short, is acquiring medical marijuana-focused cultivation and processing facilities with the aim of leasing them for extended periods of time. While acquisitions are IIP’s primary source of growth, investors should keep in mind that inflation-driven rent increases and a property management fee based on the annual rental price are passed on to tenants annually. Thus, a modest organic growth component is integrated into the operating model.

As of mid-August, IIP owned 74 properties with 6.9 million square feet of lettable space in 18 states. The more important number is that 100% of this area has been rented, with a weighted average rental period of 16.6 years. It should take less than half of that time for the company to fully repay the capital invested.

The icing on the cake for Innovative Industrial Properties is that the lack of cannabis banking reform in the US has worked in their favor. The companys Sale-leaseback program is particularly popular with multi-state operators.

It’s a fast-growing income stock that could double your money by 2026.

A generic white drug tablet with a dollar sign stamped on it.

Image source: Getty Images.

Viatris: 3% yield

Another market-leading dividend stock with all the tools it needs to double investor money by 2026 is the pharmaceutical company Viatris (NASDAQ: VTRS). If the name doesn’t ring, it’s because it was formed from the combination of less than a year ago Pfizer‘s established pharmaceutical division Upjohn and the generic drug manufacturer Mylan.

As a combined company, Viatris is expected to perform better and to be able to achieve more from a growth perspective than Upjohn and Mylan would ever have been able to do as a stand-alone company. While joining forces left the company with approximately $ 26 billion in debt, a quarter of that debt ($ 6.5 billion) is expected to will be paid off by the end of 2023. Once its debt levels get below $ 20 billion, the company may consider share buybacks and will almost certainly invest in new drug development.

Another thing that is being overlooked about Viatris is the key role it will play in the generics space. Since generics have significantly lower margins than branded drugs, volume is important. With the list prices of branded drugs soaring, it only makes sense that the use of generic drugs will increase over time. Patients and insurers will try to cut costs, as will generic drug developers are the obvious beneficiaries.

Viatris is dirt cheap too, which could be a selling point for value investors. It has generated $ 2 billion in operating cash flow over the past 12 months and can be purchased for less than four times projected earnings per share in 2021. If you set a return of 3%, you have a recipe for success.

Ascending stacks of coins in front of a two-story house.

Image source: Getty Images.

Annaly Capital Management: 10.1% return

No list of market-leading dividend stocks is ever complete without one Annaly Capital Management (NYSE: NLY)I believe it is Top Ultra High Yield Dividend Stock Income seekers can buy. Between its double-digit yield and its upside potential, this mortgage REIT is capable of doubling investors’ money by 2026.

As I described with AGNC Investment, mortgage REITs are in the sweet spot of their growth cycle. Pretty much every decade-long economic recovery has steepened the yield curve. As long-term returns rise, Annaly should be able to earn a higher average return on the MBS she has purchased. At the same time, short-term borrowing costs should remain unchanged or rise more slowly. This is a formula for widening the net interest margin.

Another key factor in Annaly’s (and AGNC’s) success is its focus on agency-backed securities. These are assets that are secured by the federal government in the event of a default. As of June 30, $ 66.5 billion of the $ 69 billion in securities held were Agency MBSs. While this added protection will lower the returns on these securities, it also allows the company to use leverage to increase its profit potential.

Since its inception in 1997, Annaly distributed more than $ 20 billion in dividends to shareholders. It also has an average return of around 10% over the past two decades. It’s a good bet to consistently deliver for your shareholders until at least the middle of the decade.

This article represents the opinion of the author who may disagree with the “official” referral position of a premium advisory service from the Motley Fool. We are colorful! Questioning an investment thesis – even one of our own – helps us all think critically about investing and make decisions that will help us get smarter, happier, and richer.

5 Excessive-Yield Dividend Shares That Can Double Your Cash by 2029

There are many ways to make money on Wall Street. But if there is one common theme among the best performing portfolios, it is that they often rely on it Dividend stocks.

In 2013, JP Morgan Asset Management released a report showing how dominant dividend stocks are compared to publicly traded companies that don’t pay dividends. Between 1972 and 2012, companies that initiated and increased their payouts averaged an annual profit of 9.5%. By comparison, ineligible stocks only posted a meager annualized return of 1.6% over the same period.

These results should come as no surprise. Because most dividend stocks are profitable and have proven operating models, they are the ideal place for long-term investors and income seekers to park their money.

The dilemma for income seekers is how to get the highest possible income with the least risk. However, There is a tendency for there to be a correlation between risk and return as soon as you get into the high-yield category (over 4%).

Image source: Getty Images.

However, this is not the case for the following five high yield stocks. These proven companies should continue to benefit investors through price increases and returns. I believe they can double your initial investment by 2029 (or sooner).

Annaly Capital Management: 10.3% return

For income seekers who prefer the dividend to do most of the heavy lifting, the Mortgage Real Estate Investment Trust (REIT) Annaly Capital Management (NYSE: NLY) is a good bet to double your money by or before 2029. If you were to reinvest your payouts at that 10.3% return, Annaly’s dividend alone would Double your initial investment in seven years.

Mortgage REITs like Annaly seek to borrow money at lower short-term rates in order to buy mortgage-backed securities (MBS) with higher long-term returns. The aim is to maximize the difference between the average long-term MBS rate of return and the average interest rate on debt, known as the net interest margin. When the yield curve steepens during an economic recovery, net interest margins tend to widen. As the US economy regains its foothold, Annaly’s core business and earnings potential should improve.

Annaly is also helped by her ability to carefully rely on leverage to increase her earnings potential. Since the majority of the assets are securities of the agency – that is, those protected from default by the federal government – Annaly can borrow more money to grow her profits and fund her hefty dividend.

On a final note, Annaly has averaged a dividend yield of around 10% over the past two decades and has paid out over $ 20 billion in dividends since it was founded nearly a quarter of a century ago.

A laboratory researcher uses a pipette to add liquid samples to a test cup.

Image source: Getty Images.

AbbVie: 4.4% return

At the other end of the high-yield dividend spectrum, at least on this list, it says pharmaceutical warehouse AbbVie (NYSE: ABBV). Given its 4.4% return, modest growth potential, and insane value proposition, AbbVie has all the tools needed to double investor money by 2029, if not sooner.

There is no question that the anti-inflammatory drug Humira will play a huge role in AbbVie’s long-term success. Before the mammoth sales related to coronavirus vaccines, Humira was the best-selling drug in the world. It has 10 approved indications in the US, 14 internationally, and has annual sales of nearly $ 20 billion in 2021, based on the $ 9.94 billion registered in the first six months of the year. Despite the potential for biosimilar competition in the US in the coming years, Humiras offers multiple approved indications and generally strong pricing power for AbbVie to generate significant cash flow from its top drug.

Beyond Humira, AbbVie has turned to acquisitions to diversify its source of income and continue to support its cash flow. In May 2020, the company closed a cash-and-stock deal to purchase Allergan. Aside from being instantly profitable, the transaction provides additional cash flow for research and development and gives AbbVie another blockbuster presence with Botox, which has cosmetic and therapeutic uses.

With less than nine times future earnings, AbbVie sees each part as a bargain for value investors and income seekers.

A small pyramid of tobacco cigarettes lying on a thin bed of tobacco shavings.

Image source: Getty Images.

Altria Group: 7.1% return

I’ll be the first to admit that Tobacco stocks aren’t the sexy growth story they once were. But when the going gets tough, few industries have delivered more consistent performance to investors in the long run. By 2029, Altria Group (NYSE: MO), the company behind the premium US cigarette brand Marlboro, is a great choice for doubling investor money.

To put it bluntly, tobacco volume metrics have been going in the wrong direction for decades. As people became better educated about the negative health effects of tobacco use, fewer adults have chosen to light themselves. Interestingly, however, that didn’t hurt Altria as much as you think. The company has exceptionally strong pricing power, thanks in part to the addictive nature of nicotine, and has been able to raise prices to offset the decline in the volume of cigarettes.

Besides, Altria is invest aggressively in your future. It introduces the IQOS heated tobacco system (licensed in the US by Philip Morris International) into a number of emerging US markets and owns 45% of Canadian marijuana stocks Cronos group. Expect Altria to work hand in hand with Cronos to develop vape products and develop a marketing strategy.

With Altria offering investors a 7.1% dividend yield, it would only take a small increase in price for Altria to double your money by or before 2029.

An engineer connecting cables to the back of a data center server tower.

Image source: Getty Images.

IBM: 4.7% return

For the past decade IBM (NYSE: IBM) has roughly the same attraction as drying paint. The technician waited too long to shift his focus to cloud computing. As a result, sales for its legacy businesses have reversed. But after a decade of transformation a new IBM is flourishing which in turn can deliver for its shareholders.

At the end of the June quarter, IBM had cloud revenue of $ 7 billion, up 13% over the same period last year. More importantly, cloud sales accounted for 37% of total sales. Because cloud margins are significantly higher than the margins associated with IBM’s legacy operations, they are key to increasing the company’s operating cash flow. As a reminder, IBM loves to use its cash flow to pay its hefty 4.7% dividend, buy back its shares, and make purchases (mostly in the cloud space).

It’s also worth noting that IBM decided to focus on Hybrid cloud solutions – those that combine public and private clouds – that allow data to be shared between the two platforms. The hybrid cloud is perfect for big data projects in which IBM has always excelled. It’s also great for a hybrid work environment where remote workers have been a common theme since the pandemic began.

IBM is unlikely to return to its former glory. However, doubling your initial investment by 2029 versus reinvesting dividends and rising prices seems very doable.

An engineer speaks to a walkie talkie while standing next to the pipeline infrastructure.

Image source: Getty Images.

Partner for corporate products: 8.3% return

One final high yield dividend stock that can double your money by 2029 or sooner thanks to its superior payout and share price is a master limited partnership Partner for corporate products (NYSE: EPD).

After last year, I can imagine the idea of ​​owning Oil stocks has a low priority for some investors. This is because a historic decline in crude oil demand has ruined the operating performance and balance sheets of most drilling companies.

However, Enterprise Products Partners was hardly concerned as it is a midstream operator. In other words, it controls more than 50,000 miles of pipeline and 14 billion cubic feet of natural gas storage space in addition to more than a dozen processing facilities.

The company’s take-or-pay contracts are designed in such a way that the majority of sales and cash flow are highly transparent. This allows the company to spend capital on infrastructure projects without worrying about hurting its earnings potential or hurting its lucrative dividend, which stood at 8.3% last weekend.

Another notable feature of Enterprise Products Partners is the dividend. The enterprise has increased its annual base payout for 22 consecutive years, and its distribution coverage ratio didn’t fall below 1.6 during the pandemic (anything below 1 would mean an unsustainable payout). With incredible cash flow visibility and a willingness to spend on new infrastructure projects, Enterprise Products Partners is a great choice for doubling investor money by 2029.

This article represents the opinion of the author who may disagree with the “official” referral position of a premium advisory service from the Motley Fool. We are colorful! Questioning an investment thesis – even one of our own – helps us all think critically about investing and make decisions that will help us get smarter, happier, and richer.

Covid vaccinations greater than double in Arkansas, Mississippi, Louisiana, Alabama

A man will be vaccinated against COVID-19 at a vaccination festival in New Orleans, New Orleans, Louisiana, United States, on May 28, 2021.

Lan Wei | Xinhua News Agency | Getty Images

More and more people who were once hesitant in several southern states are now getting their first vaccinations as the Delta-Covid variant is tearing through areas of the United States with low vaccination rates.

Arkansas, Mississippi, Louisiana, and Alabama have more than doubled the seven-day average of daily first-doses reported since early July, data from the Centers for Disease Control and Prevention shows, as the outbreak worsened nationwide.

Over the same period, the average daily case number is unvaccinated from about 13,000 per day across the country to about 94,000 per day on the 4th.

“Americans are clearly seeing the effects of not being vaccinated and unprotected, and they are responding by doing their part, rolling up their sleeves and getting vaccinated,” White House Covid Tsar Jeff Zients said Thursday to reporters.

In Arkansas, which has the third worst outbreak in the country, based on new cases per capita every day, vaccinations nearly tripled. On July 1, the state administered a seven-day average of 2,893 first doses in the arms, which, according to a CNBC analysis of CDC data, represented new people receiving their first shots. By August 4, that number shot to a seven-day average of 8,585 first doses per day.

Mississippi, which saw the country’s fourth worst eruption, rose 109% through the 4th.

Louisiana is experiencing the worst per capita outbreak of new Covid cases in the country, recording hospital admissions after the Delta variant targeted the state’s mostly unvaccinated population.

The state governor has reintroduced a mask mandate until at least September 1 to slow down the transmission. Although, despite the recent surge in vaccinations, Louisiana still ranks fifth lowest in the country when it comes to fully vaccinated residents at 37.2%.

Behind Louisiana is Arkansas with 37% of the fully vaccinated population, Wyoming with 36.7%, Mississippi with 34.8% and Alabama with 34.6%, according to CDC data.

Covid cases with serious consequences are also increasing, according to US officials. The seven-day average of daily hospital admissions is up 41% from a week, with the average daily death toll up 39%, said CDC director Dr. Rochelle Walensky on Thursday.

Studies have shown that the Delta variant, unlike the original Covid strain, is much more transmissible and requires two doses of vaccine to give the body a chance to fight against infection and severe symptoms.

“Even if someone decided to get the vaccine today, it will be some time before their body and immune system are able to cope with it,” said Gigi Gronvall, immunologist and senior scientist at the Johns Hopkins Center for Health Safety, said CNBC. “You want to make sure you aren’t exposed before your body has a chance to turn the virus off.”

Still, residents in severely affected states who start vaccinating will help slow the spread of the virus sooner rather than later and could prevent future hospitalizations and deaths.

Patients of different ages hospitalized with Covid in states like Missouri, Florida, Arkansas and Louisiana express their regret and ask their communities to get vaccinated after initially not receiving the vaccination.

Overall, the US reported an average of about 677,000 daily vaccinations last week (as of August 4), an 11% increase over the previous week.

The number of first vaccine doses increases faster than the overall rate. According to the CDC, an average of about 446,000 first doses were given daily for the past seven days, 17% more than the week before.

1 Dow Jones Inventory That Might Double Your Cash

When we think of Dow Jones stocks, we think of solid companies that have delivered steady profits and income over time. We can also think of annual dividend payments. Some stocks in the index – such as Johnson & Johnson and coke – have even increased their dividends 50 years in a row. Such investments are the backbone of many portfolios.

These stocks are usually safe bets. And that’s great. However, that doesn’t mean their stock performance is limited. In fact, there is one Dow Jones stock that could double your money. The digital business soared during the worst part of the pandemic. And the future after the pandemic looks bright. Which company are we talking about? Continue reading…

Image source: Getty Images.

Ready for the pandemic

One more tip: think of sports, brand strength, and basketball legend Michael Jordan. This Dow stock is none other than the sportswear giant Nike (NYSE: NO). The company’s timing was right when it launched a digital and direct-to-consumer plan in 2017. When the pandemic broke out, Nike was ready. Most of its stores are temporarily closed. And it missed sports-related sales – they were canceled.

But Nike’s digital sales were increasing. The company also focused on its membership program and used its apps to keep fans connected. Nike even launched products digitally through its sneakers app. All of this helped Nike recover quickly after the retailer opened its physical stores.

The company’s most recent quarter has a lot in store for us positive evidence about the future. Nike announced fourth quarter earnings last month. During the quarter, some stores in other parts of the world were temporarily closed. But North America had reopened as vaccinations increased and coronavirus cases decreased.

Quarterly revenue rose 96% year over year to $ 12.3 billion. Of course, last year’s period has been weak due to the health crisis. It is therefore useful to compare the sales figures with a time before the pandemic. And we see growth there too – sales increased 21% compared to the fourth quarter of 2019. Net income for the full year rose 126% to $ 5.7 billion. One of Nike’s greatest success stories is the Jordan brand – even 18 years after the basketball player retired. The brand had sales of nearly $ 5 billion for the fiscal year.

Keys to recovery and future growth

Nike’s digital platform was key to recovery. But it is also the key to future growth. Experts say consumer habits will stay the same when shopping online. This is great news for Nike. The company says digital sales now represent 35% of its business – that’s three years ahead of the original plan. Nike expects that number to reach 50% by fiscal 2025.

Nike’s loyalty program members will also drive growth. The company now has 300 million members. They have “proven to be a compelling driver for repeat engagement and purchases in digital and physical retail,” said CEO John J. Donahoe on last month’s conference call.

Currently, Nike stock trades at around $ 160. A look at another sportswear retailer with brand strength shows us that Nike could come a lot higher.

Lululemon Athletica, a maker of yoga-inspired clothing, sells for more than double the price of Nike. But Nike beats this company when it comes to profits and sales. And Nike is trading for less in terms of future earnings estimates. At today’s level, Nike stock looks like a bargain.

NKE Net Income (Annual) Chart

NKE net income (annually) Data from YCharts

Of course, a big surge is unlikely to happen overnight. But Nike has a lot of catalysts to be stable Gains over time – and after all, all the positive news could very well double the stock price – and your money.

This article represents the opinion of the author who may disagree with the “official” referral position of a premium advisory service from the Motley Fool. We are colorful! Questioning an investment thesis – even one of our own – helps us all think critically about investing and make decisions that will help us get smarter, happier, and richer.

Three Confirmed Methods to Double Your Cash

Investing in the stock market can be a challenge. The investment options seem endless, the market is prone to volatility, and choosing the wrong stocks could destroy your long-term savings.

Fortunately, there are ways to make your money grow with very little effort. These three strategies can help you maximize your potential income while limiting your risk.

Image source: Getty Images.

1. Earn your employer match

Contributing to your 401 (k) is one of the easiest ways to invest, and maximizing your employer match can help you save more than you might think.

Not all employers offer matching 401 (k) posts, but if your plan does, it is wise to take full advantage of this. Average agreement is around 3.5% of a worker’s wages, according to the Bureau of Labor Statistics. In other words, for every dollar you invest in your 401 (k), your employer pays up to 3.5% of your salary.

This instantly doubles your money and your savings can accumulate significantly over time. For example, let’s say you make $ 60,000 a year and your employer pays up to 3.5% of your salary, or $ 2,100 a year. Also, let’s say you have a modest average annual return of 8% on your investments.

If you consistently earn the full match, that will be around $ 238,000 per year after 30 years. If you include your own contributions as well, you have more than $ 475,000 total, all other factors stay the same.

2. Invest in S&P 500 ETFs

Some investors like to pick stocks and do research on different companies, while others prefer to take a solid approach to investing. If you fall into the second category, index ETFs can be a fantastic option.

Index ETFs are collections of stocks that are bundled in a single investment and specific stock market indices such as the S&P 500. If you were to invest in an S&P 500 ETF, you would be investing in all of the stocks in the S&P 500 itself.

If you have enough time, you can easily double your money with this type of investment. Historically, the S&P 500 has achieved an average return of around 10% per year since its inception. This means that while the index has experienced significant volatility over the years, the record highs offset the dips and average returns of around 10% per year.

So if you invested $ 10,000 today, how long would it take to double your money? If you made no additional contributions and had an average annual return of 10%, you would have made $ 20,000 in savings in about 8 years.

Also, keep in mind that S&P 500 ETFs are a “drop and forget” asset. So all you have to do is invest your money, sit back and wait.

3. Keep your investments as long as possible

While some investors use short-term strategies to make money (such as day trading), these tactics can be extremely risky. And often they look more like gambling than real investing.

One surefire way to generate wealth is to buy solid assets and hold them for the long term. If the companies you invest in are strong, they will likely grow over time. As they grow, so should their stock prices, and your portfolio will appreciate in value.

When investing for the long term, you don’t have to worry about stock market volatility either. Strong companies are more likely Survive market turmoil, and their stock prices should rebound. When you fill your portfolio with strong stocks, you can be sure that your investments will recover no matter what the market does.

Investing in the stock market can be intimidating. But with the right strategy, you can easily double your money and send your savings to the moon.

Three Biotech ETFs That Might Double Your Cash by 2025 With Zero Effort

Between the unpredictable twists and turns of the clinical trial process and the endless mysteries of human health, investing in biotech stocks is quite risky. Treatment candidates that appear promising often fail, and most investors lack the science to properly assess the merits of a company’s technology platform or drugs under development.

So, for those looking to benefit from the long-term growth of the biotech industry – which is apparently just beginning – buy Exchange Traded Funds (ETFs) Instead of individual stocks can be a solid strategy. These ETFs own an abundance of stocks across the industry. So while the overwhelming success of one company won’t have a huge impact on your investment returns, the failure of another won’t take much of a bite out of you either.

There are a number of biotech ETF options available to investors, each with their own thematic focus and risk profile, but I prefer these three for one simple, compelling reason: They have historically outperformed the market.

Image source: Getty Images.

1. SPDR S&P Biotech ETF

With a net worth of $ 7.54 billion SPDR S&P Biotech ETF (NYSEMKT: XBI) has been one of the largest in the industry since it was founded in 2006. It holds stakes in emerging stars like Modern as well as clinical-stage competitors such as Humane and Vaxart. Overall, the fund focuses on small-cap biotechs that prepared for massive growth at some point in the future, so don’t expect to find many profitable or established companies on its list.

The SPDR S&P Biotech ETF turns over 66% of its holdings each year, ensuring that investors continue to participate in potential winners and all of their stocks from the S&P Biotechnology Select Industry Index. In terms of cost, it is Expense ratio of 0.35% is lower than the biotech ETF category average of around 0.5%, but not by much. And compared to the S&P 500, the dividend yield of 0.25% is quite low. If you’re looking for broad exposure to the biotech industry, this ETF is one of the best options. However, if you prefer to focus your investments on companies pursuing a particular area of ​​therapy development, it is far too diversified.

2. Global X Genomics and Biotechnology ETF

Founded in April 2019, Global X Genomics and Biotechnology ETF (NASDAQ: GNOM) is on the smaller side of biotech ETFs with net worth just under $ 215.94 million. As the name suggests, investment is focused on companies that can benefit from breakthroughs and new technologies in genomics. Its holdings include profitable gene sequencing giants like lighting as well as biotechs like Intellia therapeutics, an impressive company, even if it does not yet have an approved product on the market. These companies’ stocks are unlikely to double in a day based on good news from a clinical trial, but they are also less likely to collapse under the opposite circumstances.

Because this ETF is a mix of companies with different maturities, the stocks held by this ETF are more mid-caps than small-caps. The 0.5% expense ratio is about average, but that won’t ruin your returns. The lack of a dividend yield is a disadvantage, but the ETF has still beaten the market in its existence to date.

^ SPX chart

^ SPX Data from YCharts

3. iShares Genomics, Immunology and Healthcare ETF

The iShares Genomics, Immunology and Healthcare ETF (NYSEMKT: IDNA) invests in companies around the world that could benefit from advances in biotechnology, genomics and immunology. It was founded in June 2019 and holds stocks like Moderna and BioNTech, as well as pharmaceutical giants like Gilead Sciences and Sanofi. Most of his largest holdings are mature companies with at least one source of recurring income. So expect the earnings season to be the most common catalyst for notable stock price movements.

In theory, investors in these ETFs are exposed to a steady growth rate that is less risky than the norm in the biotech industry. With a net worth of $ 290.71 million, it’s a bit smaller and its expense ratio of 0.47% is average. While this ETF’s dividend yield is 0.26% higher than any other I’ve discussed today, it probably shouldn’t be the focus of investors.

One thing that sets this ETF apart from the other two I mentioned is that it has a broader representation of international stocks. As a result, it is less exposed to risks from changes in national regulations on drug development processes or drug pricing, as these risks are typically confined to individual markets.

This article represents the opinion of the author who may disagree with the “official” referral position of a premium advisory service from the Motley Fool. We are colorful! Questioning an investment thesis – even one of our own – helps us all think critically about investing and make decisions that will help us get smarter, happier, and richer.

5 Easy Methods Investing Can Double Your Cash

If you invest long enough, it is possible that you will end up with twice as much money as you did when you started. It is incredible to accomplish this feat, and accomplishing it without spending extra money is even better!

However, it can be done, and it’s easier than you probably think. Here’s how long it would take, depending on how your accounts are split between stocks and bonds.

Image source: Getty Images

The rule of 72

The rule of 72 is a popular way to estimate how long it will take to double your investment Asset allocation model. You just take the number 72 and divide the rate of return that you think you can expect. So if you think you will make 10% over the life of your investments, it would take roughly 72/10 = 7.2 years to turn $ 100,000 into $ 200,000.

A conservative portfolio

A portfolio that is 100% bonds would be considered conservative, and that allocation would have one average return of 6.1% between 1926 and 2020. Under the rule of 72, it would take 11.8 years to double your investment at that rate.

A moderately conservative portfolio

If you had added 30% stocks to your accounts during this period, your average return would have grown to 7.7%. According to the rule of 72, you would have twice as much money in 9.4 years.

A balanced portfolio

If you had a balanced portfolio, you’d hold 50% stocks and 50% bonds, and your return would have risen to 8.2% on average. At this rate of return, after around 8.8 years, you could double what you started with.

A growth portfolio

With a growth portfolio, you would have owned roughly 70% stocks and 30% bonds, and your return on that period would have been 9.4%. At that rate of return, it would take 7.7 years to double your money.

An aggressive growth portfolio

If you owned all of the stocks, your accounts would be considered aggressive and would have grown an average of 10.3% each year. And according to the rule of 72, the value of your account would have doubled after 7 years.

Asset allocation Return Time to double up
Conservative 6.1% 12 years
Moderately conservative 7.7% 9.4 years
Balanced 8.2% 8.8 years
growth 9.4% 7.7 years
Aggressive growth 10.3% 7 years

Author’s calculations.

Risk tolerances

It may be tempting to pick a return with the lowest number of doubling years, but this can make your goals even more difficult. These predictions of when your money could double are based on consistency and only missing some of the best Stock market Days could cut your returns a lot.

For example, if you had invested in the S&P 500 from January 2, 2000 through December 31, 2020, you would have an average return of 7.5% and your money would have doubled every 9.6 years. But missing the 10 best days in this 20 year period would have dropped your return to 3.35% – and with that return it would take 21 years to double your investments!

It is also possible that your willingness to take risks diminishes as you age. If so, you may find that you have an aggressive portfolio in your early working years, a growth portfolio in your middle years, and a more conservative portfolio in your final years. The time it takes to double your accounts uses an average of these different asset allocation models rather than just one.

Past performance does not guarantee future performance

You would have received these returns over the past 94 years – but over shorter periods of time, the returns you get can vary quite a bit. When you’ve invested $ 10,000 Large-cap stocks on January 2, 2000, you would have had an average return of 1.59% and a final account balance of $ 11,300 over the next seven years. This is mainly because the decade started with 3 negative years of returns due to the bursting of the dot-com bubble. Conversely, if you had started investing in January 2010, you would have narrowly missed the Great Recession and seven years later had an average return of 13.89% and about $ 28,300 – more than double your original investment.

This shows that this rule is not an exact science and is subject to the whims of different market cycles. Therefore Time in the market is so important. The longer your money can stay invested, the better the chances that your investments will double.

Doubling your money may seem impossible or extremely difficult, but it is an attainable goal that you can achieve. And to get there, you don’t have to take any nasty risk or volatility. Just giving your accounts enough time to grow.

three Confirmed Methods to Double Your Cash | Enterprise

For example, imagine that the value of Scruffy’s Chicken Shack has quadrupled in value in the past two years. Amazing, isn’t it? Is it underrated or overrated? Yes you can crack some numbers and come with a sense of how much of a bargain it is. Remember, however, that there is no precise value for a company. All estimates are just that – estimates. Let’s say Scruffy’s market value, its market cap, is $ 2 billion. The stock has risen from $ 500 million to $ 2 billion in the short term. After some valuation metrics, it might have overtaken itself. But if the entire chicken market it could win is worth $ 10-15 billion, there is clearly room for more growth if the company executes its strategy well. It could double in value in the coming years. So one could argue that it is undervalued compared to what you expect in the future. (Of course, if the current valuation were lower, there would be more to win and bigger profits to be expected.)

Consider not just holding onto it the store of growth or valuebut instead aim to learn from both and look for investments that could be both growing strongly and undervalued. Whatever you do, if you invest in wonderful, growing companies and hold on to them for many years (as long as you believe in them), you will likely do well in the stock market and have a good chance of doubling your money – maybe many times over.